Luminous Ventures

Conundrum specializes in Industrial AI software for metal, mining, and steel industries. Its platform offers tools for building efficient enterprise-scale AI applications, simplifying data science, and enhancing sustainability.

Founded in 2013, Ellipsis Health is a technology company that uses artificial intelligence to improve behavioral health. It analyzes patient speech and clinical data to predict health outcomes and provide real-time assessments for conditions like depression.

Treos Bio, Inc. is a clinical-stage biotechnology company focused on developing precision cancer immunotherapies that are tailored to individual patients' genetic profiles. Founded in 2013 and headquartered in San Francisco, California, Treos Bio employs advanced computational data science and proprietary biomarkers to create targeted immunotherapies. Its product offerings include the PEPI test, which analyzes genetic data from saliva or blood samples to predict a person’s immune response to specific antigens. The company also produces PolyPEPI immunotherapy vaccines designed for various cancers, including melanoma, lung, breast, colorectal, ovarian, glioma, and leukemia. Additionally, Treos Bio offers the PolyPEPI CDx companion diagnostic test to determine the effectiveness of treatments for individual patients, as well as a Melanoma Screening Test that identifies individuals at high risk for melanoma based on genetic information.

LGN Innovations, Inc. specializes in artificial intelligence-based perception systems that aim to replicate human-level perception in autonomous technologies. Founded in 2018 and headquartered in San Francisco, with additional offices in London and Zagreb, the company develops innovative products such as LGN Auto-Calibrate, which connects AI systems to sensor arrays, and LGN Intelligent Select, which efficiently compresses and filters data. Their technology enhances the resolution and imaging capabilities of various devices, facilitating applications across multiple sectors, including automotive, retail, and satellite industries. By optimizing data capture and processing, LGN's solutions reduce costs and power consumption while promoting high-level autonomy, making advanced AI capabilities accessible to a broader range of industries.

Cytoseek Limited is a biotechnology company based in Bristol, United Kingdom, that specializes in developing innovative cell therapies aimed at treating cancer, heart disease, osteoarthritis, and diabetic wound healing. Founded in 2017 as a spinout from the University of Bristol, Cytoseek focuses on cell membrane augmentation technology, which enhances the functionality of cell therapies by enabling tissue-specific targeting and improving cell survivability. The company is currently conducting proof of principle studies to validate the efficacy of its technologies and is actively seeking partnerships with other cell therapy organizations to advance its products towards clinical application, with the overarching goal of improving human health.

Magdrive Limited, established in 2019 and headquartered in Didcot, United Kingdom, specializes in developing advanced spacecraft propulsion systems tailored for small satellites. The company's innovative technology features a plasma thruster that combines the high thrust of chemical rockets with the high efficiency of electric thrusters. This dual capability allows spacecraft to travel faster and longer while reducing propellant requirements, thereby lowering costs and improving fuel efficiency for satellite maneuvers and missions in Low Earth Orbit (LEO).

Biomage is a company dedicated to advancing life sciences through innovative single-cell analysis. It offers a platform that enables researchers to analyze vast single-cell sequencing data efficiently, transforming complex biological data into actionable insights. This capability supports both academic and industrial scientists in enhancing drug target discovery while reducing costs. The Biomage Single Cell Platform allows users to manage their single-cell data analysis with ease, providing deep biological insights in a streamlined manner. By applying advanced computational methods, Biomage is at the forefront of facilitating groundbreaking research across various biological disciplines.

Kernal Biologics, Inc. is a biotechnology company focused on designing and developing mRNA immunotherapies aimed at treating diseases such as COVID-19 and various cancers. Founded in 2016 and headquartered in Cambridge, Massachusetts, the company leverages its mRNA platform to enable researchers and organizations to create vaccines and therapeutics. Kernal’s innovative approach allows specific cells to produce their own therapeutic agents. With a team that has strong connections to prestigious institutions like MIT and Harvard, as well as experience in the pharmaceutical industry, Kernal Biologics has garnered recognition for its work, winning multiple awards from notable organizations, including Amgen and NASA.

Founded in 2017, Phenomic AI is a Toronto-based company that develops artificial intelligence-driven drug discovery platforms. Its technology analyzes phenotypes in complex disease models like high-content co-culture and 3D assays, enabling pharmaceutical companies to discover drugs more efficiently.

Climax Foods Inc. is a plant-based food company based in Berkeley, California, that leverages artificial intelligence to create alternatives to animal-based products. Founded in 2019, Climax Foods employs a combination of data science, machine learning, and predictive modeling to enhance food innovation processes. The company's technology focuses on rapid experimentation to develop dairy alternatives that excel in taste, texture, nutrition, and cost-effectiveness. By optimizing these aspects, Climax Foods enables its clients to produce plant-based foods that can effectively compete with traditional animal-based options, aiming to transform the global food production system.

Universal Quantum Ltd, established in 2018 and located in England, focuses on the development of quantum computers that utilize silicon technology to address complex real-world challenges. The company’s innovative approach involves performing calculations through the application of voltages to a microchip, leveraging ultrafast electric field links to create a scalable architecture for qubits. This design enables Universal Quantum to provide high computational power at a competitive cost, positioning it to solve problems that would take contemporary supercomputers billions of years to address.

Temporall is a developer of an AI-driven workplace intelligence platform that assists organizations in enhancing their effectiveness. By aggregating and connecting fragmented data across a company, Temporall employs artificial intelligence and machine learning techniques to analyze this information and extract valuable insights. The platform is designed to support leadership teams by offering expert recommendations and comprehensive reporting, ultimately guiding clients toward performance optimization. Positioned at the intersection of enterprise software and organizational science, Temporall combines advanced technology with human expertise to address the strategic needs of its clients.

Oxford VR Limited is a company that specializes in developing cognitive treatments for clinical conditions utilizing virtual reality technology. Founded in 2016 and based in Oxford, United Kingdom, it emerged as a spin-out from Oxford University, building on the research of Professor Daniel Freeman. The company offers automated treatments delivered by a virtual coach, targeting conditions such as fear of heights, psychosis, and social anxiety. By leveraging immersive virtual reality, Oxford VR aims to provide faster and more effective therapies at a lower cost to health providers. The treatments are designed to be user-centered and clinically validated, thereby enhancing access to mental health care while significantly impacting patients and the broader healthcare system.

Mahana Therapeutics, Inc. is a company focused on developing digital treatments for individuals with chronic health conditions, particularly gastrointestinal diseases. Its flagship offering, Parallel, is a clinically validated, minimal-contact digital program specifically designed for patients suffering from irritable bowel syndrome (IBS). The program aims to deliver both physical and psychological support to enhance patient well-being. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also maintains an office in London, United Kingdom. The company was previously known as Mahana Health, Inc. before rebranding in July 2019.

LGN Innovations, Inc. specializes in artificial intelligence-based perception systems that aim to replicate human-level perception in autonomous technologies. Founded in 2018 and headquartered in San Francisco, with additional offices in London and Zagreb, the company develops innovative products such as LGN Auto-Calibrate, which connects AI systems to sensor arrays, and LGN Intelligent Select, which efficiently compresses and filters data. Their technology enhances the resolution and imaging capabilities of various devices, facilitating applications across multiple sectors, including automotive, retail, and satellite industries. By optimizing data capture and processing, LGN's solutions reduce costs and power consumption while promoting high-level autonomy, making advanced AI capabilities accessible to a broader range of industries.

Optellum Ltd is a UK-based company founded in 2015 that specializes in artificial intelligence clinical decision support software specifically for lung cancer diagnosis and treatment. The company has developed an imaging biomarker aimed at enhancing the early detection of lung cancer, the most prevalent and deadly form of cancer globally. Optellum's innovative platform leverages machine learning to analyze vast patient datasets, enabling personalized diagnosis and therapy management for patients at high risk of developing lung cancer. The software not only identifies at-risk patients but also facilitates optimal therapy by automating the analysis of radiology reports, thereby improving clinical decision-making. The founding team consists of experts in medical imaging software and AI, with experience in successfully bringing innovations to market. Optellum is supported by a distinguished Advisory Board of clinicians and deep learning specialists, and is actively expanding its product development team to further its mission in cancer care.

Astroscreen Ltd is a London-based company that specializes in developing a software as a service (SaaS) platform aimed at detecting astroturfing campaigns and social media manipulation. Incorporated in 2018, Astroscreen utilizes advanced machine learning techniques alongside human intelligence to identify fake accounts, botnets, and spam on social networks. Its platform supports disinformation analysts by verifying social media influence engagement and cleaning data streams, thereby enabling clients to combat marketing fraud and protect against harmful manipulation. By providing accurate insights into social media analytics, Astroscreen helps brands maintain their integrity and defend democracy from deceptive practices online.

Hadean is a venture-backed startup specializing in distributed cloud computing for web 3.0 applications and the metaverse. Their platform enables unprecedented scale and fidelity in digital realms, enhancing physical experiences.

Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that integrate devices, software, and services to support patients in monitoring their health and managing diseases. By bridging the gap between diagnosis and treatment, Vital Bio aims to empower patients and healthcare providers alike, promoting proactive care and reducing disparities in health outcomes. The company's innovative approach seeks to enhance the overall healthcare experience, ensuring that individuals have greater control over their health management.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

BioBeats, established in 2012 and headquartered in London, specializes in digital health solutions for personal wellness. The company leverages artificial intelligence and real-time data from smartphones and wearables to tackle global mental health challenges. By fusing research from the University of Oxford, BioBeats creates AI products that track neurological and physiological correlates to psychological progress, predict disorder onset, and provide personalized support. Their psychological wellness application calculates a baseline wellbeing score and offers insights into stress responses, enabling users to identify harmful patterns and improve their overall mental health.

FaceSoft is developing machine learning models and databases that improve 3D facial recognition and computer-generated facial reconstruction technologies. The spinout's reconstruction algorithm has been trained on a database of 2.5 million high-resolution 3D facial scans. The company was founded in 2017 and based in London, England.

Beyond Limited operates a platform that enables users to compare funeral director prices, services, and reviews in the United Kingdom. Founded in 2015 and based in London, the company provides various solutions related to end-of-life planning, including arrangements for direct cremation, funeral financing, will writing, and estate settlement. Formerly known as Funeralbooker Ltd, Beyond aims to assist customers in making informed decisions during a difficult time.

Active Global Specialised Caregivers Pte Ltd is a Singapore-based company that specializes in providing comprehensive caregiving services tailored to individuals with various health conditions. Established in 2012, the company offers home personal care, live-in caregiver support, and respite care. Its services cater to patients dealing with a range of medical issues, including cancer, dementia, diabetes, stroke, heart disease, Parkinson’s disease, visual and hearing impairments, as well as challenges related to nutrition, elimination, schizophrenia, stomas, wounds, and allergies. Through its specialized offerings, Active Global Specialised Caregivers aims to enhance the quality of life for its clients and provide essential support to families in need of caregiving assistance.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Sparrho is a London-based company that operates a discovery platform designed to make scientific information more accessible. Founded in 2013 by two Oxbridge scientists, the platform aggregates, distills, and recommends relevant content from a wide array of scientific sources, including journals, patents, and conference materials. It offers customized, filtered recommendations to users, allowing them to add content and sources, as well as save, share, and disseminate discoveries. By leveraging a unique combination of artificial intelligence and expertise from PhD professionals, Sparrho enhances the literature search experience and caters to a diverse clientele, including Fortune 500 companies around the world. The company was previously known as Epistora.

Hadean is a venture-backed startup specializing in distributed cloud computing for web 3.0 applications and the metaverse. Their platform enables unprecedented scale and fidelity in digital realms, enhancing physical experiences.

Beyond Limited operates a platform that enables users to compare funeral director prices, services, and reviews in the United Kingdom. Founded in 2015 and based in London, the company provides various solutions related to end-of-life planning, including arrangements for direct cremation, funeral financing, will writing, and estate settlement. Formerly known as Funeralbooker Ltd, Beyond aims to assist customers in making informed decisions during a difficult time.

BioBeats, established in 2012 and headquartered in London, specializes in digital health solutions for personal wellness. The company leverages artificial intelligence and real-time data from smartphones and wearables to tackle global mental health challenges. By fusing research from the University of Oxford, BioBeats creates AI products that track neurological and physiological correlates to psychological progress, predict disorder onset, and provide personalized support. Their psychological wellness application calculates a baseline wellbeing score and offers insights into stress responses, enabling users to identify harmful patterns and improve their overall mental health.